Seven Bridges

About:

Seven Bridges is the leading biomedical data science company.

Website: https://www.sevenbridges.com/

Twitter/X: SBGenomics

Top Investors: First Star Ventures, Kryssen Capital

Description:

Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.

Total Funding Amount:

$113M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Charlestown, Massachusetts, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)sbgenomics.com

Founders:

Deniz Kural, Igor Bogicevic

Number of Employees:

251-500

Last Funding Date:

2021-04-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai